Molecular Formula | C17H37NO8 |
Molar Mass | 383.48 |
Density | 1.054 |
Boling Point | 448.0±40.0 °C(Predicted) |
Appearance | Morphological solid or viscous liquid |
pKa | 8.74±0.10(Predicted) |
Storage Condition | -20°C |
Physical and Chemical Properties | Bioactive m-PEG8-Amine is a degradable (cleavable) ADC linker used in the synthesis of antibody-coupled drugs (ADCs). |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
target
CleavablePEGs
in vitro study
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
biological activity | m-PEG8-Amine is a degradable (cleavable) ADC linker used for antibody-coupled drugs (ADCs) synthesis. |
target | Cleavable PEGs |
in vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |